Market Closed - Nasdaq 04:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
6.95 USD +0.29% Intraday chart for Inogen, Inc. -6.08% +26.59%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Top Midday Decliners MT
Top Premarket Decliners MT
Transcript : Inogen, Inc., Q4 2023 Earnings Call, Feb 27, 2024
Earnings Flash (INGN) INOGEN Posts Q4 Revenue $75.9M, vs. Street Est of $77M MT
Inogen, Inc. Provides Earnings Guidance for the First Quarter 2024 CI
Inogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Inogen, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
North American Morning Briefing : S&P 500 Seen -2- DJ
Sector Update: Health Care Stocks Higher Late Afternoon MT
Sector Update: Health Care MT
Inogen Shares Rise After Upgrade From William Blair MT
William Blair Upgrades Inogen to Outperform From Market Perform MT
Inogen Names Michael Bourque as Finance Chief MT
Inogen, Inc. Announces CFO Changes, Effective March 4, 2024 CI
Inogen, Inc. Announces Executive Changes, Effective March 4, 2024 CI
North American Morning Briefing : Boeing Drags Down Dow Futures DJ
Inogen Appoints Gregoire Ramade as Chief Commercial Officer; Shares Rise MT
Inogen, Inc. Appoints Grgoire Ramade to Serve as Chief Commercial Officer CI
Inogen, Inc. Announces Separation Agreement with Nabil Shabshab CI
Inogen Appoints Kevin Smith as Chief Executive MT
Inogen Announces Board Changes CI
Inogen Announces CEO Changes CI
Transcript : Inogen, Inc., Q3 2023 Earnings Call, Nov 07, 2023
Earnings Flash (INGN) INOGEN Reports Q3 Revenue $84M, vs. Street Est of $82.1M MT
Inogen, Inc. Provides Earnings Guidance for the Fiscal Year 2023 CI
Chart Inogen, Inc.
More charts
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
6.95 USD
Average target price
6.5 USD
Spread / Average Target
-6.47%
Consensus
  1. Stock Market
  2. Equities
  3. INGN Stock
  4. News Inogen, Inc.
  5. Earnings Flash (INGN) INOGEN Reports Q2 Revenue $103.4M